Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard J., Temple E., Wang A., Smith A., Pollock S., Ford G., Hobbs R., Kenealy N., De Lusignan S., McCartney D., Yu L-M., McManus R.